PUF Ventures Inc. announced that the company has appointed Dr. Peter Tolias to its Advisory Board. The Advisory Board oversees all areas of research and development related to PUF's medical cannabis initiatives. Dr. Peter Tolias is currently Professor and Chair of the Department of Chemistry and Chemical Biology and Director of the Center for Healthcare Innovation at the Stevens Institute of Technology. He is the founder of several biotechnology companies plus a capital sourcing and consulting firm specializing in the biotechnology sector. Dr. Tolias' academic and corporate expertise includes molecular, cellular and developmental biology, microbiology, immunology, genetics, genomics, proteomics and tissue engineering.